- Home
- TOI vs HCWB Comparison
TOI vs HCWB Comparison
Compare TOI & HCWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOI
- HCWB
- Stock Information
- Founded
- TOI 2007
- HCWB 2018
- Country
- TOI United States
- HCWB United States
- Employees
- TOI N/A
- HCWB N/A
- Industry
- TOI Medical/Nursing Services
- HCWB Biotechnology: Pharmaceutical Preparations
- Sector
- TOI Health Care
- HCWB Health Care
- Exchange
- TOI Nasdaq
- HCWB Nasdaq
- Market Cap
- TOI 22.7M
- HCWB 26.6M
- IPO Year
- TOI N/A
- HCWB 2021
- Fundamental
- Price
- TOI $0.32
- HCWB $0.45
- Analyst Decision
- TOI Strong Buy
- HCWB
- Analyst Count
- TOI 1
- HCWB 0
- Target Price
- TOI $2.50
- HCWB N/A
- AVG Volume (30 Days)
- TOI 73.8K
- HCWB 17.5K
- Earning Date
- TOI 11-06-2024
- HCWB 11-12-2024
- Dividend Yield
- TOI N/A
- HCWB N/A
- EPS Growth
- TOI N/A
- HCWB N/A
- EPS
- TOI N/A
- HCWB N/A
- Revenue
- TOI $361,067,000.00
- HCWB $3,922,670.00
- Revenue This Year
- TOI $29.17
- HCWB N/A
- Revenue Next Year
- TOI $16.43
- HCWB N/A
- P/E Ratio
- TOI N/A
- HCWB N/A
- Revenue Growth
- TOI 23.31
- HCWB 2.82
- 52 Week Low
- TOI $0.27
- HCWB $0.40
- 52 Week High
- TOI $2.66
- HCWB $2.14
- Technical
- Relative Strength Index (RSI)
- TOI 47.54
- HCWB 41.14
- Support Level
- TOI $0.29
- HCWB $0.44
- Resistance Level
- TOI $0.34
- HCWB $0.60
- Average True Range (ATR)
- TOI 0.02
- HCWB 0.07
- MACD
- TOI 0.01
- HCWB -0.01
- Stochastic Oscillator
- TOI 65.42
- HCWB 4.34
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.
About HCWB HCW Biologics Inc.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.